San Diego Health Policy Conference
9th Annual San Diego Health Policy Conference
"Technology and Global Health"
WHAT: 9th Annual San Diego Health Policy Conference, "Technology and Global Health"
The rapidly developing technologies in research, online marketing, material transport, and pharmaceutical manufacturing have created great promise in promoting global health. Yet there are also potential risks associated with these advancing technologies, with systemic vulnerabilities arising from an increasingly connected global marketplace. What are some of these risks and benefits to global health? What lessons and policies can we adopt from other sectors? How have ethical norms changed due to the digital world and global access? This conference will explore some of these questions to begin to assess their scope and impact upon global health.
Friday, March 22, 2013
WHERE: Hilton Harbor Island, 1960 Harbor Island Drive, San Diego, CA 92101
Professor Bryan A. Liang, M.D., Ph.D., J.D. Dr. Liang is Professor of Anesthesiology and Director, San Diego Center for Patient Safety, University of California, San Diego School of Medicine; Shapiro Distinguished Professor of Health Law and Executive Director, Institute of Health Law Studies, California Western School of Law; and Medical and Legal Director, Joint Program in Health Policy, UC San Diego-California Western School of Law. His research focus is patient safety and global health policy.
Commander James Balcius, M.S., M.S.P.H. Commander Balcius is currently assigned to Marine Forces Command in Norfolk, Virginia as the lead United States Marine Corps Naval Operational Aerospace Physiologist. He is also a PhD candidate in the Joint Doctoral Program in Global Health, University of California, San Diego School of Medicine-San Diego State University School of Public Health. His area of research focuses on the Department of Defense’s strategic health engagement program as a collaborative global health effort facilitating national security objectives.
Thomas Kubic. Mr. Kubic is former Deputy Assistant Director of the Federal Bureau of Investigation, and is currently President and CEO of the Pharmaceutical Security Institute. He has global experience in the fight against counterfeit drugs, and has worked with the public and private sectors in promoting safety of the global drug supply chain.
Timothy K. Mackey, M.A.S. Mr. Mackey is Senior Research Associate, Institute of Health Law Studies, California Western School of Law; Clinical Instructor (Health Sciences), Department of Anesthesiology, University of California, San Diego School of Medicine; Coordinator of Global Health Research, Joint Program in Health Policy, UC San Diego-California Western School of Law; and PhD candidate, Joint Doctoral Program in Global Health, University of California, San Diego School of Medicine-San Diego State University School of Public Health. His work focuses upon global health policy and governance.
John Theriault, M.B.A. Mr. Theriault has been Vice President for Security for Pfizer, Inc., and Apple Computer, and developed counterfeiting monitoring programs for drugs such as Viagra. He currently serves on the Institute of Medicine Committee on Understanding the Global Public Health Implications of Counterfeit, Falsified, and Substandard Drugs.
ACCREDITATION: The Institute of Health Law Studies at California Western School of Law is the only law school in the nation that is CME Certified in Continuing Medical Education. California Western is also an approved MCLE provider so this conference offers both CME and CLE credits for attendees.
All conference papers will be published and disseminated broadly to consumer, professional, and policy communities.
For more information, contact Ms. Pam Tait at the Institute of Health Law Studies: 619-515-1568 or email@example.com